Animal Antimicrobials-North America Market Status and Trend Report 2013-2023
Report Summary
Animal Antimicrobials-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Antimicrobials industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Animal Antimicrobials 2013-2017, and development forecast 2018-2023
Main market players of Animal Antimicrobials in North America, with company and product introduction, position in the Animal Antimicrobials market
Market status and development trend of Animal Antimicrobials by types and applications
Cost and profit status of Animal Antimicrobials, and marketing status
Market growth drivers and challenges
The report segments the North America Animal Antimicrobials market as:
North America Animal Antimicrobials Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Animal Antimicrobials Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Premixes
Oral Powders
Oral Solutions
Injections
Others
North America Animal Antimicrobials Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Food-producing Animals
Companion Animals
North America Animal Antimicrobials Market: Players Segment Analysis (Company and Product introduction, Animal Antimicrobials Sales Volume, Revenue, Price and Gross Margin):
Zoetis, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck & Co., Inc.
Bayer AG
Sanofi
Ceva Sante Animale
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals PLC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Animal Antimicrobials-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Antimicrobials industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Animal Antimicrobials 2013-2017, and development forecast 2018-2023
Main market players of Animal Antimicrobials in North America, with company and product introduction, position in the Animal Antimicrobials market
Market status and development trend of Animal Antimicrobials by types and applications
Cost and profit status of Animal Antimicrobials, and marketing status
Market growth drivers and challenges
The report segments the North America Animal Antimicrobials market as:
North America Animal Antimicrobials Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Animal Antimicrobials Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Premixes
Oral Powders
Oral Solutions
Injections
Others
North America Animal Antimicrobials Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Food-producing Animals
Companion Animals
North America Animal Antimicrobials Market: Players Segment Analysis (Company and Product introduction, Animal Antimicrobials Sales Volume, Revenue, Price and Gross Margin):
Zoetis, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck & Co., Inc.
Bayer AG
Sanofi
Ceva Sante Animale
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals PLC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ANIMAL ANTIMICROBIALS
1.1 Definition of Animal Antimicrobials in This Report
1.2 Commercial Types of Animal Antimicrobials
1.2.1 Premixes
1.2.2 Oral Powders
1.2.3 Oral Solutions
1.2.4 Injections
1.2.5 Others
1.3 Downstream Application of Animal Antimicrobials
1.3.1 Food-producing Animals
1.3.2 Companion Animals
1.4 Development History of Animal Antimicrobials
1.5 Market Status and Trend of Animal Antimicrobials 2013-2023
1.5.1 North America Animal Antimicrobials Market Status and Trend 2013-2023
1.5.2 Regional Animal Antimicrobials Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Animal Antimicrobials in North America 2013-2017
2.2 Consumption Market of Animal Antimicrobials in North America by Regions
2.2.1 Consumption Volume of Animal Antimicrobials in North America by Regions
2.2.2 Revenue of Animal Antimicrobials in North America by Regions
2.3 Market Analysis of Animal Antimicrobials in North America by Regions
2.3.1 Market Analysis of Animal Antimicrobials in United States 2013-2017
2.3.2 Market Analysis of Animal Antimicrobials in Canada 2013-2017
2.3.3 Market Analysis of Animal Antimicrobials in Mexico 2013-2017
2.4 Market Development Forecast of Animal Antimicrobials in North America 2018-2023
2.4.1 Market Development Forecast of Animal Antimicrobials in North America 2018-2023
2.4.2 Market Development Forecast of Animal Antimicrobials by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Animal Antimicrobials in North America by Types
3.1.2 Revenue of Animal Antimicrobials in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Animal Antimicrobials in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Animal Antimicrobials in North America by Downstream Industry
4.2 Demand Volume of Animal Antimicrobials by Downstream Industry in Major Countries
4.2.1 Demand Volume of Animal Antimicrobials by Downstream Industry in United States
4.2.2 Demand Volume of Animal Antimicrobials by Downstream Industry in Canada
4.2.3 Demand Volume of Animal Antimicrobials by Downstream Industry in Mexico
4.3 Market Forecast of Animal Antimicrobials in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL ANTIMICROBIALS
5.1 North America Economy Situation and Trend Overview
5.2 Animal Antimicrobials Downstream Industry Situation and Trend Overview
CHAPTER 6 ANIMAL ANTIMICROBIALS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Animal Antimicrobials in North America by Major Players
6.2 Revenue of Animal Antimicrobials in North America by Major Players
6.3 Basic Information of Animal Antimicrobials by Major Players
6.3.1 Headquarters Location and Established Time of Animal Antimicrobials Major Players
6.3.2 Employees and Revenue Level of Animal Antimicrobials Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ANIMAL ANTIMICROBIALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis, Inc.
7.1.1 Company profile
7.1.2 Representative Animal Antimicrobials Product
7.1.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Zoetis, Inc.
7.2 Boehringer Ingelheim GmbH
7.2.1 Company profile
7.2.2 Representative Animal Antimicrobials Product
7.2.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH
7.3 Eli Lilly and Company
7.3.1 Company profile
7.3.2 Representative Animal Antimicrobials Product
7.3.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
7.4 Merck & Co., Inc.
7.4.1 Company profile
7.4.2 Representative Animal Antimicrobials Product
7.4.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Merck & Co., Inc.
7.5 Bayer AG
7.5.1 Company profile
7.5.2 Representative Animal Antimicrobials Product
7.5.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Bayer AG
7.6 Sanofi
7.6.1 Company profile
7.6.2 Representative Animal Antimicrobials Product
7.6.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Sanofi
7.7 Ceva Sante Animale
7.7.1 Company profile
7.7.2 Representative Animal Antimicrobials Product
7.7.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Ceva Sante Animale
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Animal Antimicrobials Product
7.8.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Virbac
7.9 Vetoquinol S.A.
7.9.1 Company profile
7.9.2 Representative Animal Antimicrobials Product
7.9.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Vetoquinol S.A.
7.10 Dechra Pharmaceuticals PLC
7.10.1 Company profile
7.10.2 Representative Animal Antimicrobials Product
7.10.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Dechra Pharmaceuticals PLC
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL ANTIMICROBIALS
8.1 Industry Chain of Animal Antimicrobials
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ANIMAL ANTIMICROBIALS
9.1 Cost Structure Analysis of Animal Antimicrobials
9.2 Raw Materials Cost Analysis of Animal Antimicrobials
9.3 Labor Cost Analysis of Animal Antimicrobials
9.4 Manufacturing Expenses Analysis of Animal Antimicrobials
CHAPTER 10 MARKETING STATUS ANALYSIS OF ANIMAL ANTIMICROBIALS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Animal Antimicrobials in This Report
1.2 Commercial Types of Animal Antimicrobials
1.2.1 Premixes
1.2.2 Oral Powders
1.2.3 Oral Solutions
1.2.4 Injections
1.2.5 Others
1.3 Downstream Application of Animal Antimicrobials
1.3.1 Food-producing Animals
1.3.2 Companion Animals
1.4 Development History of Animal Antimicrobials
1.5 Market Status and Trend of Animal Antimicrobials 2013-2023
1.5.1 North America Animal Antimicrobials Market Status and Trend 2013-2023
1.5.2 Regional Animal Antimicrobials Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Animal Antimicrobials in North America 2013-2017
2.2 Consumption Market of Animal Antimicrobials in North America by Regions
2.2.1 Consumption Volume of Animal Antimicrobials in North America by Regions
2.2.2 Revenue of Animal Antimicrobials in North America by Regions
2.3 Market Analysis of Animal Antimicrobials in North America by Regions
2.3.1 Market Analysis of Animal Antimicrobials in United States 2013-2017
2.3.2 Market Analysis of Animal Antimicrobials in Canada 2013-2017
2.3.3 Market Analysis of Animal Antimicrobials in Mexico 2013-2017
2.4 Market Development Forecast of Animal Antimicrobials in North America 2018-2023
2.4.1 Market Development Forecast of Animal Antimicrobials in North America 2018-2023
2.4.2 Market Development Forecast of Animal Antimicrobials by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Animal Antimicrobials in North America by Types
3.1.2 Revenue of Animal Antimicrobials in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Animal Antimicrobials in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Animal Antimicrobials in North America by Downstream Industry
4.2 Demand Volume of Animal Antimicrobials by Downstream Industry in Major Countries
4.2.1 Demand Volume of Animal Antimicrobials by Downstream Industry in United States
4.2.2 Demand Volume of Animal Antimicrobials by Downstream Industry in Canada
4.2.3 Demand Volume of Animal Antimicrobials by Downstream Industry in Mexico
4.3 Market Forecast of Animal Antimicrobials in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL ANTIMICROBIALS
5.1 North America Economy Situation and Trend Overview
5.2 Animal Antimicrobials Downstream Industry Situation and Trend Overview
CHAPTER 6 ANIMAL ANTIMICROBIALS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Animal Antimicrobials in North America by Major Players
6.2 Revenue of Animal Antimicrobials in North America by Major Players
6.3 Basic Information of Animal Antimicrobials by Major Players
6.3.1 Headquarters Location and Established Time of Animal Antimicrobials Major Players
6.3.2 Employees and Revenue Level of Animal Antimicrobials Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ANIMAL ANTIMICROBIALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis, Inc.
7.1.1 Company profile
7.1.2 Representative Animal Antimicrobials Product
7.1.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Zoetis, Inc.
7.2 Boehringer Ingelheim GmbH
7.2.1 Company profile
7.2.2 Representative Animal Antimicrobials Product
7.2.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH
7.3 Eli Lilly and Company
7.3.1 Company profile
7.3.2 Representative Animal Antimicrobials Product
7.3.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
7.4 Merck & Co., Inc.
7.4.1 Company profile
7.4.2 Representative Animal Antimicrobials Product
7.4.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Merck & Co., Inc.
7.5 Bayer AG
7.5.1 Company profile
7.5.2 Representative Animal Antimicrobials Product
7.5.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Bayer AG
7.6 Sanofi
7.6.1 Company profile
7.6.2 Representative Animal Antimicrobials Product
7.6.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Sanofi
7.7 Ceva Sante Animale
7.7.1 Company profile
7.7.2 Representative Animal Antimicrobials Product
7.7.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Ceva Sante Animale
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Animal Antimicrobials Product
7.8.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Virbac
7.9 Vetoquinol S.A.
7.9.1 Company profile
7.9.2 Representative Animal Antimicrobials Product
7.9.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Vetoquinol S.A.
7.10 Dechra Pharmaceuticals PLC
7.10.1 Company profile
7.10.2 Representative Animal Antimicrobials Product
7.10.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Dechra Pharmaceuticals PLC
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL ANTIMICROBIALS
8.1 Industry Chain of Animal Antimicrobials
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ANIMAL ANTIMICROBIALS
9.1 Cost Structure Analysis of Animal Antimicrobials
9.2 Raw Materials Cost Analysis of Animal Antimicrobials
9.3 Labor Cost Analysis of Animal Antimicrobials
9.4 Manufacturing Expenses Analysis of Animal Antimicrobials
CHAPTER 10 MARKETING STATUS ANALYSIS OF ANIMAL ANTIMICROBIALS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference